BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
calcium channel activity
,
Allergy to pollen
,
Pancreas
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
abarelix
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
GNRHR
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
Gonadotropin-releasing hormone receptor
Gonadotrophin-releasing hormone receptor family
REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS
BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP
BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Explore Curated Studies Results
Literature
Most Relevant Literature
New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone s…
New treatment paradigm for prostate cancer: abarelix initiation therapy for immediate testosterone s…
Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abare…
Abarelix and other gonadotrophin-releasing hormone antagonists in prostate cancer.
Utility of LHRH antagonists for advanced prostate cancer.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Abarelix Versus Goserelin Plus Bicalutamide in Patients With Advanced or Metastatic Prostate Cancer
Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy
The Plenaxis® Experience Study
Selenomethionine in Treating Patients Undergoing Surgery or Internal Radiation Therapy for Stage I o…
Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational R…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ